Medication-induced tardive dyskinesia: a review and update

EM Cornett, M Novitch, AD Kaye, V Kata… - Ochsner …, 2017 - ochsnerjournal.org
Background: Tardive dyskinesia (TD) is a movement disorder that causes involuntary,
repetitive body movements and is commonly seen in patients who are on long-term …

[HTML][HTML] Management of tardive syndrome: medications and surgical treatments

SA Factor - Neurotherapeutics, 2020 - Springer
Tardive syndrome (TS) is an iatrogenic, often persistent movement disorder caused by drugs
that block dopamine receptors. It has a broad phenotype including movement …

[HTML][HTML] Japanese society of neuropsychopharmacology:“Guideline for pharmacological therapy of schizophrenia”

JS of Neuropsychopharmacology - Neuropsychopharmacology …, 2021 - ncbi.nlm.nih.gov
Guidelines for schizophrenia treatment have been created in various countries and have
been translated and used in Japan as well. However, the available drugs and their …

[HTML][HTML] Antipsychotic maintenance treatment: time to rethink?

J Moncrieff - PLoS medicine, 2015 - journals.plos.org
Antipsychotic Maintenance Treatment: Time to Rethink? | PLOS Medicine Skip to main content
Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues Collections …

A modified Delphi consensus study of the screening, diagnosis, and treatment of tardive dyskinesia

SN Caroff, L Citrome, J Meyer, M Sajatovic… - The Journal of clinical …, 2020 - psychiatrist.com
Objective: A nominal group process followed by a modified Delphi method was used to
survey expert opinions on best practices for tardive dyskinesia (TD) screening, diagnosis …

Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia

JM Meyer - CNS spectrums, 2016 - cambridge.org
The broad use of atypical antipsychotics was expected to dramatically reduce the
prevalence and incidence of tardive dyskinesia (TD), but data show that TD remains an …

The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia

P Sienaert, P van Harten, D Rhebergen - Handbook of clinical neurology, 2019 - Elsevier
Although highly prevalent, motor syndromes in psychiatry and motor side effects of
psychopharmacologic agents remain understudied. Catatonia is a syndrome with specific …

Psychoeducation improves compliance and outcome in schizophrenia without an increase of adverse side effects: A 7-year follow-up of the Munich PIP-study

J Bäuml, G Pitschel-Walz, A Volz, S Lüscher… - Schizophrenia …, 2016 - academic.oup.com
Psychoeducation improves adherence and motivates patients to accept a maintenance
therapy as recommended by the guidelines. This would mean a daily consumption of at …

Therapeutic D evelopments for T ics and M yoclonus

J Jankovic - Movement Disorders, 2015 - Wiley Online Library
Tics and myoclonus are phenomenologically similar given that both are jerk‐like
movements, but, in contrast to myoclonus, tics are often preceded by premonitory sensations …

[HTML][HTML] Recent advances in the pharmacology of tardive dyskinesia

SN Caroff - Clinical Psychopharmacology and Neuroscience, 2020 - ncbi.nlm.nih.gov
Tardive dyskinesia (TD) is a syndrome of abnormal involuntary movements that follows
treatment with dopamine D2-receptor antagonists. Recent approval of vesicular monoamine …